The US Food and Drug Administration (FDA) has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System. The solution enables real-time localisation ...
MINNEAPOLIS, May 15, 2025 (GLOBE NEWSWIRE) -- Elucent Medical ("Elucent”), a leading innovator in the field of guided surgical technologies, announced today that the U.S. Food and Drug Administration ...
MINNEAPOLIS, July 31, 2025 (GLOBE NEWSWIRE) -- Elucent Medical is proud to announce that more than 25,000 successful procedures have been performed using the EnVisio® In-Body Spatial Intelligence™ ...
PENSACOLA, FL, UNITED STATES, January 3, 2024 /EINPresswire.com/ -- Lovell ® Government Services and Elucent Medical, creator of the EnVisio ® Surgical Navigation ...